Sealantis acquired for $25 million: 5 things to know

Written by Shayna Korol | February 04, 2019 | Print  |

Advanced Medical Solutions Group acquired surgical sealant company Sealantis.

Five things to know:

1. Sealantis is an Israeli-based medical device company that develops an alginate-based tissue adhesive technology platform.

2. Sealantis’ flagship surgical sealant product Seal-G is open surgery device already designed to reinforce the staple or suture line to minimize anastomotic leaks after gastrointestinal surgery..

3. AMS is acquiring Sealantis for an initial consideration of $25 million in cash, which is to be funded from existing cash resources.

4. Additionally, AMS will pay royalties on future sales of Sealantis’ existing products in development until the end of 2027.

5. AMS plans to accelerate the commercialization of Seal-G by running clinical trials for anastomotic leak prevention as well as obtaining approval for new indications. It expects to make a total investment of approximately $10.4 million in research and development, regulatory and clinical costs over the next three years.

More articles on gastroenterology:
Gastroenterologist completes Oklahoma's 1st procedures with truFreeze Spray Cryotherapy — 4 insights
New device detects esophageal disorders — 5 insights
Fight CRC, U of Colorado researchers host workshop to explore early-onset CRC — 5 insights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.